[1] National Center for AIDS & STD Control and Prevention, The Chinese Center for Disease Control and Prevention (CDC). Annals of Information on Comprehensive Prevention and Treatment for AIDS, STD and Hepatitis C; 2020 July 9; Beijing, China.
[2] Gao DS, Zou ZY, Dong B, Zhang WJ, Chen TQ, Cui WX, et al. Secular trends in HIV/AIDS mortality in China from 1990 to 2016: gender disparities. PLoS One 2019;14(7):e0219689. http://dx.doi.org/10.1371/journal.pone.0219689CrossRef
[3] Dong MJ, Peng B, Liu ZF, Ye QN, Liu H, Lu XL, et al. The prevalence of HIV among MSM in China: a large-scale systematic analysis. BMC Infect Dis 2019;19(1):1000. http://dx.doi.org/10.1186/s12879-019-4559-1CrossRef
[4] Feng YB, Bu K, Li M, Zhang XY, Jin SS, Wang L. Meta-analysis of HIV infection incidence and risk factors among men who have sex with men in China. Chin J Epidemiol 2015;36(7):752 − 8. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2015.07.019 (In Chinese). CrossRef
[5] Cui Y, Guo W, Li D, Wang L, Shi CX, Brookmeyer R, et al. Estimating HIV incidence among key affected populations in China from serial cross-sectional surveys in 2010-2014. J Int AIDS Soc 2016;19(1):20609. http://dx.doi.org/10.7448/IAS.19.1.20609CrossRef
[6] Chen Q, Sun YM, Sun WD, Hao MQ, Li GY, Su XL, et al. Trends of HIV incidence and prevalence among men who have sex with men in Beijing, China: nine consecutive cross-sectional surveys, 2008-2016. PLoS One 2018;13(8):e0201953. http://dx.doi.org/10.1371/journal.pone.0201953CrossRef
[7] Han M, Pan PL, Wu GH, Zhou C, Yao Y, Luo J, et al. Estimating HIV incidence rates among MSM in an urban area of Chongqing using three approaches. Biomed Environ Sci 2017;30(12):913 − 6. http://dx.doi.org/10.3967/bes2017.122CrossRef
[8] Zhang J, Xu JJ, Song W, Pan S, Chu ZX, Hu QH, et al. HIV incidence and care linkage among MSM first-time-testers in Shenyang, China, 2012-2014. AIDS Behav 2018;22(3):711 − 21. http://dx.doi.org/10.1007/s10461-017-1840-4CrossRef
[9] Yang H, Ye L, Su L, Liu Y, Xiao L, Hu Y, et al. An analysis on incidence of HIV-1 epidemics among men who have sex with men in Sichuan Province during 2011−2015. Chin J Prev Med 2019;53(3):327−9. http://med.wanfangdata.com.cn/Paper/Detail?dbid=WF_QK&id=PeriodicalPaper_zhyfyx201903028. (In Chinese). http://med.wanfangdata.com.cn/Paper/Detail?dbid=WF_QK&id=PeriodicalPaper_zhyfyx201903028
[10] Cheng WB, Xu HF, Tang WM, Zhong F, Meng G, Han ZG, et al. Online HIV prevention intervention on condomless sex among men who have sex with men: a web-based randomized controlled trial. BMC Infect Dis 2019;19(1):644. http://dx.doi.org/10.1186/s12879-019-4251-5CrossRef
[11] Xu JJ, Huang XJ, Liu XC, Wang LM, Chen YK, Wang H, et al. Chinese experts’ consensus on the use of HIV pre-exposure prophylaxis. Chin J AIDS STD 2020;26(11):1265 − 71. http://dx.doi.org/10.13419/j.cnki.aids.2020.11.34 (In Chinese). CrossRef
[12] National Center for AIDS/STD Control and Prevention, China CDC. Technical Guideline for HIV Post-Exposure Prophylaxis (Trial). http://ncaids.chinacdc.cn/zxzx/zxzx/202011/t20201116_222780.htm. [2020-11-16]http://ncaids.chinacdc.cn/zxzx/zxzx/202011/t20201116_222780.htm
[13] Yun K, Chu ZX, Zhang J, Geng WQ, Jiang YJ, Dong W, et al. Mobile phone intervention based on an HIV risk prediction tool for HIV prevention among men who have sex with men in China: randomized controlled trial. JMIR Mhealth Uhealth 2021;9(4):e19511. http://dx.doi.org/10.2196/19511CrossRef
[14] Hu QH, Qian HZ, Li JM, Leuba SI, Chu ZX, Turner D, et al. Assisted partner notification and uptake of HIV testing among men who have sex with men: a randomized controlled trial in China. Lancet Reg Health West Pac 2021;12:100171. http://dx.doi.org/10.1016/j.lanwpc.2021.100171CrossRef
[15] Tang WM, Wei CY, Cao BL, Wu D, Li KT, Lu HD, et al. Crowdsourcing to expand HIV testing among men who have sex with men in China: a closed cohort stepped wedge cluster randomized controlled trial. PLoS Med 2018;15(8):e1002645. http://dx.doi.org/10.1371/journal.pmed.1002645CrossRef
[16] Wu D, Zhou Y, Yang N, Huang SZ, He X, Tucker J, et al. Social media-based secondary distribution of human immunodeficiency virus/syphilis self-testing among Chinese men who have sex with men. Clin Infect Dis 2021;73(7):e2251 − 7. http://dx.doi.org/10.1093/cid/ciaa825CrossRef
[17] Fu YS, Ashuro AA, Feng XX, Wang T, Zhang SC, Ye DQ, et al. Willingness to use HIV pre-exposure prophylaxis and associated factors among men who have sex with men in Liuzhou, China. AIDS Res Ther 2021;18(1):46. http://dx.doi.org/10.1186/s12981-021-00374-8CrossRef
[18] Cui Z, Huang HJ, Zhang TT, Yu ZY, Zhang HL, Yao TT, et al. Low awareness of and willingness to use PrEP in the Chinese YMSM: an alert in YMSM HIV prevention. HIV Med 2021;22(3):185 − 93. http://dx.doi.org/10.1111/hiv.12990CrossRef
[19] Wang LY, Qin QQ, Ge L, Ding ZW, Cai C, Guo W, et al. Characteristics of HIV infections among over 50-year-olds population in China. Chin J Epidemiol 2016;37(2):222 − 6. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2016.02.015 (In Chinese). CrossRef
[20] Chen HH, Wu XH, Chen L, Lu HX, Tang ZZ, Shen ZY, et al. Rapidly spreading human immunodeficiency virus epidemic among older males and associated factors: a large-scale prospective cohort study in rural Southwest China. Sex Transm Dis 2019;46(4):234 − 9. http://dx.doi.org/10.1097/OLQ.0000000000000957CrossRef
[21] Wang CP, Guo Q, Han ZR, Chen DY. Awareness rate of HIV/AIDS core knowledge among the elderly: a meta-analysis. Chin J AIDS STD 2019;25(2):148 − 52. http://dx.doi.org/10.13419/j.cnki.aids.2019.02.10 (In Chinese). CrossRef
[22] Zhang HX, Han MJ, Zhou Y, Xiu XF, Xu F, Wang L. HIV infection rate in people aged 50 years and older in China: a Meta-analysis. Chin J Epidemiol 2020;41(1):96 − 102. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2020.01.018 (In Chinese). CrossRef
[23] Cai C, Tang H, Chen F, Li D, Lyu P. Characteristics and trends of newly reported HIV infection in young students in China, 2010-2019. Chin J Epidemiol 2020;41(9):1455 − 9. http://dx.doi.org/10.3760/cma.j.cn112338-20200417-00592 (In Chinese). CrossRef
[24] Liang HX, Tang K, Cao WZ, Guo YP, Jiao Y, Zhu WY, et al. Factors influencing the acceptability of HIV/AIDS voluntary counselling and testing: a quantitative study of 41 336 female university students in China. Sex Health 2021;18(1):119 − 21. http://dx.doi.org/10.1071/SH20038CrossRef
[25] Lv Y, Li GQ, Hu MG, Xu CD, Lu HY, Chen L, et al. Anonymous linkage between college students and Human Immunodeficiency Virus (HIV) facilities: systematic evaluation of urine self-collection for HIV testing initiative in China. Clin Infect Dis 2021;73(5):e1108 − 15. http://dx.doi.org/10.1093/cid/ciaa1816CrossRef
[26] Liu TT, Wang X, Li AX, Ye JZ, Shan D, Zhang G, et al. Service acceptance of HIV non-occupational post-exposure prophylaxis(nPEP) among college students: a cross-sectional study in China. BMC Public Health 2021;21(1):1220. http://dx.doi.org/10.1186/s12889-021-11286-7CrossRef
[27] Zhang HX, Hsieh E, Wang L, Liao SS. HIV/AIDS among female sex workers in China: epidemiology and recent prevention strategies. Curr HIV/AIDS Rep 2020;17(2):151 − 60. http://dx.doi.org/10.1007/s11904-019-00477-yCrossRef
[28] Yang H, Su L, Ye L, Xiao L, Hu Y, Shen MG, et al. Incidence rates of HIV-1 epidemics among 4 high risk groups in Sichuan province during 2011-2015. Chin J Epidemiol 2017;38(12):1649 − 54. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2017.12.014 (In Chinese). CrossRef
[29] Li J, Gong XD, Yue XL, Jiang N. Dual epidemics of club drug use and sexually transmitted infections among Chinese female sex workers: new challenges to STI prevention. Biomed Res Int 2017;2017:2093421. http://dx.doi.org/10.1155/2017/2093421CrossRef
[30] Wang L, Huai PC, Jiao KD, Liu YC, Hua YM, Liu XY, et al. Awareness of and barriers to using non-occupational post-exposure prophylaxis among male clients of female sex workers in two cities of China: a qualitative study. Sex Health 2021;18(3):239 − 47. http://dx.doi.org/10.1071/SH20203CrossRef
[31] He N, Duan S, Ding YY, Rou KM, McGoogan JM, Jia MH, et al. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One 2013;8(11):e77981. http://dx.doi.org/10.1371/journal.pone.0077981CrossRef
[32] Jia ZW, Mao YR, Zhang FJ, Ruan YH, Ma Y, Li J, et al. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study. Lancet 2013;382(9899):1195 − 203. http://dx.doi.org/10.1016/S0140-6736(12)61898-4CrossRef
[33] Zhang C, Koniak-Griffin D, Qian HZ, Goldsamt LA, Wang HH, Brecht ML, et al. Impact of providing free HIV self-testing kits on frequency of testing among men who have sex with men and their sexual partners in China: a randomized controlled trial. PLoS Med 2020;17(10):e1003365. http://dx.doi.org/10.1371/journal.pmed.1003365CrossRef
[34] Yan XY, Su HX, Zhang B, Li YJ, Zhang LL, Jia ZW. Adherence of HIV self-testing among men who have sex with men in China: longitudinal study. J Med Internet Res 2020;22(9):e19627. http://dx.doi.org/10.2196/19627CrossRef
[35] Kumar N, Forastiere L, Janmohamed K, Yang F, Zhang TG, Sha YJ, et al. Improving HIV self-testing social network interventions: the role of sexual behavior disclosure among Chinese men who have sex with men. AIDS Behav 2021;25(6):1984 − 92. http://dx.doi.org/10.1007/s10461-020-03128-1CrossRef
[36] Yuan R, Cheng H, Chen LS, Zhang X, Wang B. Prevalence of different HIV-1 subtypes in sexual transmission in China: a systematic review and meta-analysis. Epidemiol Infect 2016;144(10):2144 − 53. http://dx.doi.org/10.1017/S0950268816000212CrossRef
[37] Wang XR, Zhang Y, Liu YJ, Li HP, Jia L, Han JW, et al. Phylogenetic analysis of sequences in the HIV database revealed multiple potential circulating recombinant forms in China. AIDS Res Hum Retroviruses 2021;37(9):694 − 705. http://dx.doi.org/10.1089/aid.2020.0190CrossRef
[38] Song HS, Ou WD, Feng Y, Zhang JL, Li F, Hu J, et al. Disparate impact on CD4 T cell count by two distinct HIV-1 phylogenetic clusters from the same clade. Proc Natl Acad Sci USA 2019;116(1):239 − 44. http://dx.doi.org/10.1073/pnas.1814714116CrossRef
[39] Zuo LL, Liu K, Liu HL, Hu YH, Zhang ZJ, Qin JR, et al. Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001-2017). EClinical Med 2020;18:100238. http://dx.doi.org/10.1016/j.eclinm.2019.100238CrossRef
[40] Yang ZJ, Yang X, Deng X, Wei SG, Liu J, Ma JJ, et al. Prevalence of Integrase Strand Transfer Inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020). Infection 2021 Jul 19. Online ahead of print. http://dx.doi.org/10.1007/s15010-021-01668-9.http://dx.doi.org/10.1007/s15010-021-01668-9
[41] Chang L, Zhao JP, Guo F, Ji HM, Zhang L, Jiang XY, et al. HIV-1 gp41 genetic diversity and enfuvirtide resistance-associated mutations among enfuvirtide-naive patients in southern China. Virus Res 2021;292:198215. http://dx.doi.org/10.1016/j.virusres.2020.198215CrossRef
[42] Ma N, Chen XH, Zhao Y, Kang X, Pan S, Yao WQ. HIV-1 molecular transmission network among sexually transmitted populations in Liaoning Province, China. Medicine 2021;100(28):e26640. http://dx.doi.org/10.1097/MD.0000000000026640CrossRef
[43] Yin YQ, Zhou Y, Lu J, Liu XY, Shi LG, Fu GF, et al. Molecular epidemiology of HIV-1 in Jiangsu province, Southeast China: genotypes and HIV-1 transmission networks among newly diagnosed men having sex with men in 2017. AIDS Res Hum Retroviruses 2021;37(1):62 − 9. http://dx.doi.org/10.1089/aid.2020.0165CrossRef
[44] Li K, Liu ML, Chen HH, Li JJ, Liang YL, Feng Y, et al. Using molecular transmission networks to understand the epidemic characteristics of HIV-1 CRF08_BC across China. Emerg Microbes Infect 2021;10(1):497 − 506. http://dx.doi.org/10.1080/22221751.2021.1899056CrossRef
[45] Lin HJ, He N, Zhou SJ, Ding YY, Qiu DH, Zhang TJ, et al. Behavioral and molecular tracing of risky sexual contacts in a sample of Chinese HIV-infected men who have sex with men. Am J Epidemiol 2013;177(4):343 − 50. http://dx.doi.org/10.1093/aje/kws256CrossRef
[46] Ma Y, Dou ZH, Guo W, Mao YR, Zhang FJ, McGoogan JM, et al. The human immunodeficiency virus care continuum in China: 1985-2015. Clin Infect Dis 2018;66(6):833 − 9. http://dx.doi.org/10.1093/cid/cix911CrossRef
[47] Zhao Y, Wu ZY, McGoogan JM, Shi CX, Li AH, Dou ZH, et al. Immediate antiretroviral therapy decreases mortality among patients with high CD4 counts in China: a nationwide, retrospective cohort study. Clin Infect Dis 2018;66(5):727 − 34. http://dx.doi.org/10.1093/cid/cix878CrossRef
[48] Dou ZH, Zhang FJ, Zhao Y, Jin CR, Zhao DC, Gan XM, et al. Progress on China's national free antiretroviral therapy strategy in 2002-2014. Chin J Epidemiol 2015;36(12):1345 − 50. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2015.12.005 (In Chinese). CrossRef
[49] Liu XJ, McGoogan JM, Wu ZY. Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data. Chin Med J 2021;134(10):1175 − 80. http://dx.doi.org/10.1097/CM9.0000000000001447CrossRef
[50] Zhu WM, Mao YR, Tang HL, McGoogan JM, Zhang ZF, Detels R, et al. Spectrum of malignancies among the population of adults living with HIV infection in China: a nationwide follow-up study, 2008-2011. PLoS One 2019;14(7):e0219766. http://dx.doi.org/10.1371/journal.pone.0219766CrossRef
[51] Lin HJ, Ding YY, Ning CX, Qiao XT, Chen XC, Chen XX, et al. Age-specific associations between HIV Infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART Cohort. Lancet HIV 2019;6(12):e860 − 8. http://dx.doi.org/10.1016/S2352-3018(19)30263-2CrossRef
[52] Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 2014;59(12):1787 − 97. http://dx.doi.org/10.1093/cid/ciu701CrossRef
[53] Ding Y, Duan S, Ye R, Yao S, Cao D, Yang Y, et al. Effects of aging, baseline renal function and stage of HIV infection on post-treatment changes in renal function among HIV-infected patients: a retrospective cohort study. HIV Med 2019;20(9):591 − 600. http://dx.doi.org/10.1111/hiv.12763CrossRef
[54] Ye RH, Li J, Yao ST, Wang JB, Cao DD, Zhang YD, et al. Prevalence and related factors on diabetes among HIV/AIDS receiving antiretroviral therapy in Dehong Dai and Jingpo Autonomous Prefecture. Chin J Epidemiol 2019;40(6):654 − 9. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2019.06.010 (In Chinese). CrossRef
[55] Xu X, Lin H, Chen X, Zhu B, Shen W, Ning C, et al. Differences in hypertension and prehypertension among people living with and without HIV in China: role of HIV infection and antiretroviral therapy. HIV Med 2021;22(5):409 − 17. http://dx.doi.org/10.1111/hiv.13040CrossRef
[56] Zhao TT, Wei B, Long JX, Tang XY, Zhou MX, Dang C. Cognitive disorders in HIV-infected and AIDS patients in Guangxi, China. J NeuroVirol 2015;21(1):32 − 42. http://dx.doi.org/10.1007/s13365-014-0295-xCrossRef
[57] Guo F, Song X, Li Y, Guan W, Pan W, Yu W, et al. Longitudinal change in bone mineral density among Chinese individuals with HIV after initiation of antiretroviral therapy. Osteoporos Int 2021;32(2):321 − 32. http://dx.doi.org/10.1007/s00198-020-05584-wCrossRef
[58] Wang Y, Liang HY, Zhang L, Zhang Z, Wu L, Ni L, et al. The burden of serious non-AIDS-defining events among admitted cART-naive AIDS patients in China: an observational cohort study. PLoS One 2020;15(12):e0243773. http://dx.doi.org/10.1371/journal.pone.0243773CrossRef
[59] Liu JY, Hou YY, Sun LQ, Wang LF, He Y, Zhou Y, et al. High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study. Emerg Microbes Infect 2021;10(1):416 − 23. http://dx.doi.org/10.1080/22221751.2021.1894904CrossRef
[60] Liu DP, Shen YZ, Zhang RF, Xun JN, Wang JR, Liu L, et al. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China. J Gastroenterol Hepatol 2021;36(6):1670 − 8. http://dx.doi.org/10.1111/jgh.15320CrossRef
[61] Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013;39(4):633 − 45. http://dx.doi.org/10.1016/j.immuni.2013.10.001CrossRef
[62] Sun J, Su JW, Xie YR, Yin MT, Huang Y, Xu LJ, et al. Plasma IL-6/IL-10 ratio and IL-8, LDH, and HBDH level predict the severity and the risk of death in AIDS patients with Pneumocystis pneumonia. J Immunol Res 2016;2016:1583951. http://dx.doi.org/10.1155/2016/1583951CrossRef
[63] Zhao D, Ding YY, Lin HJ, Chen XX, Shen WW, Gao MY, et al. Mitochondrial haplogroups N9 and G are associated with metabolic syndrome among human immunodeficiency virus-infected patients in China. AIDS Res Hum Retroviruses 2019;35(6):536 − 43. http://dx.doi.org/10.1089/aid.2018.0151CrossRef
[64] Ding YY, Lin HJ, Chen XX, Zhu BW, Xu XH, Xu XY, et al. Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection. EBioMedicine 2021;71:103548. http://dx.doi.org/10.1016/j.ebiom.2021.103548CrossRef
[65] Dong RH, Lin HJ, Chen XX, Shi RZ, Yuan SY, Li J, et al. Gut microbiota and fecal metabolites associated with neurocognitive impairment in HIV-infected population. Front Cell Infect Microbiol 2021;11:723840. http://dx.doi.org/10.3389/fcimb.2021.723840CrossRef
[66] Huang J, Xie N, Hu X, Yan H, Ding J, Liu P, et al. Epidemiological, virological and serological features of coronavirus disease 2019 (COVID-19) cases in people living with human immunodeficiency virus in Wuhan City: a population-based cohort study. Clin Infect Dis 2021;73(7):e2086 − 94. http://dx.doi.org/10.1093/cid/ciaa1186CrossRef
[67] Shi LG, Tang WM, Hu HY, Qiu T, Marley G, Liu XY, et al. The impact of COVID-19 pandemic on HIV care continuum in Jiangsu, China. BMC Infect Dis 2021;21(1):768. http://dx.doi.org/10.1186/s12879-021-06490-0CrossRef
[68] Jiang HB, Xie YW, Xiong Y, Zhou Y, Lin KH, Yan Y, et al. HIV self-testing partially filled the HIV testing gap among men who have sex with men in China during the COVID-19 pandemic: results from an online survey. J Int AIDS Soc 2021;24(5):e25737. http://dx.doi.org/10.1002/JIA2.25737CrossRef
[69] Huang XJ, Yu MH, Fu GF, Lan GH, Li LH, Yang JZ, et al. Willingness to receive COVID-19 vaccination among people living with HIV and AIDS in China: nationwide cross-sectional online survey. JMIR Public Health Surveill 2021;7(10):e31125. http://dx.doi.org/10.2196/31125CrossRef